Regenxbio
RGNX
RGNX
184 hedge funds and large institutions have $1.12B invested in Regenxbio in 2021 Q1 according to their latest regulatory filings, with 27 funds opening new positions, 92 increasing their positions, 34 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
184
Holders Change
-2
Holders Change %
-1.08%
% of All Funds
3.24%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
27
Increased
92
Reduced
34
Closed
27
Calls
$3.51M
Puts
$3.25M
Net Calls
+$255K
Net Calls Change
-$10.2M
Top Buyers
| 1 |
1
JPMorgan Chase & Co
New York
|
$119M |
| 2 |
2
BlackRock
New York
|
$215M |
| 3 |
3
Point72 Asset Management
Stamford,
Connecticut
|
$30.9M |
| 4 |
4
Vanguard Group
Malvern,
Pennsylvania
|
$134M |
| 5 |
5
State Street
Boston,
Massachusetts
|
$78.3M |
Top Sellers
| 1 |
1
Goldman Sachs
New York
|
$12.3M |
| 2 |
2
Citadel Advisors
Miami,
Florida
|
$3.54M |
| 3 |
3
Jane Street
New York
|
$426K |
| 4 |
WP
4
Woodline Partners
San Francisco,
California
|
$0 |
| 5 |
5
BNP Paribas Financial Markets
Paris,
France
|
$372K |
